197 related articles for article (PubMed ID: 130968)
21. Long-term influence of splenectomy on immune functions in patients with Hodgkin's disease.
Björkholm M; Askergren J; Holm G; Mellstedt H
Scand J Haematol; 1980 Jan; 24(1):87-94. PubMed ID: 6966069
[TBL] [Abstract][Full Text] [Related]
22. A micro-method for PHA-induced stimulation of human lymphocytes. II. communication: effect of splenectomy on the inhibitory activity of serum in patients with Hodgkin's disease.
Pappas A; Pees H; Girmann G
Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):1-10. PubMed ID: 868205
[TBL] [Abstract][Full Text] [Related]
23. Study of some immunological parameters in untreated patients with Hodgkin's disease.
Romagnani S; Amadori A; Maggi E; Biagiotti R; Ricci M
Int Arch Allergy Appl Immunol; 1977; 55(1-6):429-38. PubMed ID: 145416
[No Abstract] [Full Text] [Related]
24. [Comparative studies of the proportions of T, B and O-lymphocytes and of the degree of blastic transformation following stimulation with PHA in patients with Hodgkin's disease].
Pluzańska A
Pol Arch Med Wewn; 1977 Apr; 57(4):297-305. PubMed ID: 300871
[No Abstract] [Full Text] [Related]
25. [Immunological aspects of Hodgkin's disease].
Bianchini E
Minerva Med; 1975 Feb; 66(8):365-70. PubMed ID: 1078722
[TBL] [Abstract][Full Text] [Related]
26. The lymphocyte response in Hodgkin's disease.
Braeman J; Evans IH; Deeley TJ
Clin Radiol; 1975 Jul; 26(3):305-9. PubMed ID: 1081440
[TBL] [Abstract][Full Text] [Related]
27. Impaired autologous mixed lymphocyte reactivity in Hodgkin's disease.
Begemann M; Claas G; Falke H
Klin Wochenschr; 1982 Jan; 60(1):19-26. PubMed ID: 6210797
[TBL] [Abstract][Full Text] [Related]
28. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.
Hillinger SM; Herzig GP
J Clin Invest; 1978 Jun; 61(6):1620-7. PubMed ID: 149140
[TBL] [Abstract][Full Text] [Related]
29. Comparison of multiple in vivo and in vitro parameters in untreated patients with Hodgkin's disease.
Case DC; Hansen JA; Corrales E; Young CW; Dupont B; Pinsky CM; Good RA
Cancer; 1976 Oct; 38(4):1807-15. PubMed ID: 1086708
[TBL] [Abstract][Full Text] [Related]
30. [Hodgkin's disease: effect of spenectomy on the immune status (author's transl)].
Diehl V; Schaadt M; Kalden RJ; Hagedorn C; Schmidt N; Deinhardt J
Klin Wochenschr; 1978 Aug; 56(16):809-18. PubMed ID: 211317
[TBL] [Abstract][Full Text] [Related]
31. Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.
Romagnani S; Del Prete GF; Maggi E; Bellesi G; Biti G; Rossi Ferrini PL; Ricci M
J Clin Invest; 1983 May; 71(5):1375-82. PubMed ID: 6602150
[TBL] [Abstract][Full Text] [Related]
32. Hodgkin's disease in children: investigation of T and B lymphocytes.
Ilyin NV; Kolygin BA; Letsky VB; Fedoreev GA; Zubzhitsky YN
Neoplasma; 1978; 25(1):75-81. PubMed ID: 305545
[TBL] [Abstract][Full Text] [Related]
33. Lymphocyte reactivity to phytohaemagglutinin and allogeneic lymphocytes in 32 untreated patients with Hodgkin's disease.
Lang JM; Oberling F; Bigel P; Mayer S; Waitz R
Biomedicine; 1974 Sep; 21(9):372-7. PubMed ID: 4281669
[No Abstract] [Full Text] [Related]
34. [Immunity in Hodgkin's lymphoma].
Danieli G; Montroni M; Leoni P; Magelli L; Totti S
G Clin Med; 1975; 56(1):39-56. PubMed ID: 770222
[No Abstract] [Full Text] [Related]
35. [Abnormal formation of rosette (E and EAC) in Hodgkin's disease].
Lenzini L; Rottoli L; Rottoli P
Boll Soc Ital Biol Sper; 1975 Nov; 51(21):1579-83. PubMed ID: 1085157
[No Abstract] [Full Text] [Related]
36. Ecotaxis: the principle and its application to the study of Hodgkin's disease.
Sousa MD; Yang M; Lopes-Corrales E; Tan C; Hansen JA; Dupont B; Good RA
Clin Exp Immunol; 1977 Jan; 27(1):143-51. PubMed ID: 300302
[TBL] [Abstract][Full Text] [Related]
37. [T- and B-lymphocytes in lymphogranulomatosis].
Il'in NV; Letskiĭ VB; Vinokurova NA
Vopr Onkol; 1977; 23(6):9-15. PubMed ID: 303412
[TBL] [Abstract][Full Text] [Related]
38. B and T lymphocytes in Hodgkin's disease. Analysis at diagnosis and following therapy.
Gajl-Peczalska KJ; Bloomfield CD; Sosin H; Kersey JH
Clin Exp Immunol; 1976 Jan; 23(1):47-55. PubMed ID: 1083318
[TBL] [Abstract][Full Text] [Related]
39. [Cellular immunity and clinico-histological stage in Hodgkin's disease].
Fabris C; De Sanctis C; Ciriotti G; Ponzone A
Minerva Pediatr; 1971 Feb; 23(5):190-3. PubMed ID: 5574421
[No Abstract] [Full Text] [Related]
40. SPLEEN/PATHOL.
Bukowski RM; Noguchi S; Hewlett JS; Deodhar S
Am J Clin Pathol; 1976 Jan; 65(1):30-9. PubMed ID: 1082240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
